8 am – 8:10 am TP53 genetic variants identified in Brazilian women with hereditary breast cancer – systematic review of the literature
Maria Eduarda Pires Vaz (BRA)
8:10 am – 8:20 am Prognostic impact of neoadjuvant chemotherapy-induced changes in immunohistochemical markers on survival outcomes in breast cancer: a systematic review and meta-analysis
Marcelo Antonini (BRA)
8:20 am – 8:30 am A systematic review and extracted individual patient data meta-analysis of long-term outcomes in triple-negative breast cancer after a pathologic complete response: does the type of neoadjuvant therapy matter?
Renata Rodrigues da Cunha Colombo Bonadio (BRA)
8:30 am – 8:40 am Discussion
8:45 am – 9:05 am Mini conference: Neoreal: What did we learn about chemoimmunotherapy for early-stage TNBC from a Brazilian Real Life Study?
Victor Domingos Lisita Rosa (BRA)
Chairman
Romualdo Barroso de Sousa (BRA)
Speaker
9:05 am – 9:25 am Mini conference: Challenges related to the surgical approach to inflammatory carcinoma
Sergio Zerbini Borges (BRA)
Chairman
Régis Resende Paulinelli (BRA)
Speaker
9:25 am – 9:45 am Mini conference: Decoding HER2: unraveling isoform expression and its hidden complexity in breast cancer
Flávia Pinto Cardozo (BRA)
Chairworman
Carlos Henrique dos Anjos (BRA)
Speaker
9:45 am – 10:05 am Mini Conference: Treatment options for Metastatic HR+ Breast Cancer beyond CDK4/6 Inhibitors?
Dannillo Guimarães Pereira (BRA)
Chairman
Mohammad Jahanzeb (EUA)
Speaker
10:05 am – 10:20 am Coffee Break
10:20 am – 10:50 am Gold Satellite Symposium – Astrazeneca: Bridging the Gap: New therapeutical frontiers in Luminal MBC
ONLY PRESCRIBERS
Andreza Karine de Barros Almeida Souto (BRA)
Speaker
Ruana Rocha Costa (BRA)
Speaker
10:50 am – 11:10 am Mini conference: Treatment of HER2-positive disease in the CNS
Rafael de Negreiros Botan (BRA)
Chairman
Antonio Carlos Buzaid (BRA)
Speaker
11:10 am – 11:50 am Hot Topics - Surgical approach in patients with high penetrance mutation. Conservative surgery or mastectomy?
João Nunes de Matos Neto (BRA)
Coordinator
15’ Conservative surgery
Idam de Oliveira Junior (BRA)
Speaker
15’ Mastectomy
Rosemar Macedo Sousa Rahal (BRA)
Speaker
11:50 am – 12:10 pm Mini conference: Challenges in incorporating new drugs in the treatment of breast cancer
Augusto Rodrigues de Araújo Neto (BRA)
Chairman
Angelica Nogueira Rodrigues (BRA)
Speaker
12:10 pm – 12:50 pm Lecture: The best of breast cancer in the last 12 months (ASCO 2024, SABS 2024 and BBCS 2025)
Lucas Roskamp Budel (BRA)
Chairman
20’ Systemic - Cristiano Augusto Andrade de Resende (BRA)
Speaker 1
20’ Loco regional – Francisco Cavalcante Pimentel (BRA)
